Bulletin du Cancer
Volume 86, issue 3, Mars 1999
Editorial
Gustave Roussy (1874-1948): a pioneer in oncology
(p.241-3)
Christian Nezelof, Geneviève Contesso
Articles originaux
Fotemustine (Muphoran®) in 22 patients with relapses of high-grade cerebral gliomas
(p.289-94)
Jean-Pierre Malhaire, Brigitte Lucas, Hélène Simon, Hervé Person, Phong Dam-Hieu, Jean-Paul Labat
Comparative trial of oral granisetron and intravenous ondansetron in patients receiving chemotherapy for breast cancer
(p.295-301)
May Mabro, Pierre Kerbrat et le groupe d’études du granisétron
Breast cancer in Tunisia: clinical and epidemiological study
(p.302-6)
Mongi Maalej, Hatem Frikha, Sihem Ben Salem, Jamel Daoud, Noureddine Bouaouina, Mansour Ben Abdallah, Khaled Ben Romdhane
Synthèses
Cell adhesion molecules: expression and function in acute myeloid leukemia
(p.265-77)
Xavier Thomas, Bruno Anglaret
Stewart-Treves syndrom arising in posttraumatic lymphedema
(p.279-82)
Brigitte Laguerre, Claudia Lefeuvre, Pierre Kerbrat, Mohamed Hassel
High-dose melphalan in patients with multiple myeloma
(p.283-8)
Philippe Moreau, Mireille Le Bonniec, Jean-Luc Harousseau
Point sur…
NB 506
(p.255-8)
Amélie Lansiaux, Christian Bailly
Méthodologie
Meta-analyses of randomized trials in oncology: pros and cons
(p.259-64)
Catherine Hill, Jean-Pierre Pignon
Tribune libre
Recommendations for medical management of hereditary breast and ovarian cancer: the Inserm-FNCLCC ad hoc committee
(p.307-13)
François Eisinger, Nicole Alby, Alain Bremond, Jacques Dauplat, Marc Espié, Paul Janiaud, Frédérique Kuttenn, Jean-Pierre Lebrun, Jean-Pierre Lefranc, Janine Pierret, Hagay Sobol, Dominique Stoppa-Lyonnet, Dominique Thouvenin, Henri Tristant, Josué Feingold